MyAverix Finance
SA · Healthcare
argenx SE (A1RG34)
Biotechnology
argenx SE (A1RG34) is listed on SA in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $222.22B, P/E ratio is 34.93, net margin is 30.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for A1RG34
argenx SE (A1RG34) — FAQ
What is argenx SE's market cap?
argenx SE (A1RG34) has a reported market cap of $222.22B (data as of 2026-03-29).
What is A1RG34's P/E ratio?
The price-to-earnings (P/E) ratio for argenx SE (A1RG34) is 34.93 (data as of 2026-03-29).
Does argenx SE pay a dividend?
Dividend yield is not available in the current snapshot for argenx SE (A1RG34). Check the MyAverix Finance app for the latest dividend data.
What sector is argenx SE in?
argenx SE (A1RG34) is classified in the Healthcare sector (Biotechnology industry).
What exchange is A1RG34 listed on?
A1RG34 is listed on SA.
What is argenx SE's net margin?
argenx SE (A1RG34) reports a net margin of 30.5% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.